MedTrace Logo

Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants

NCT02819050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-12-10

Study results available
· View outcomes & findings →

Summary

Though Nasal Continuous Positive Airway Pressure (NCPAP) is a commonly used form of non-invasive neonatal respiratory support, the optimal method of weaning off NCPAP is not well established. In this prospective, two-center randomized control trial we hypothesize that gradually increasing time off NCPAP (sprinting) increases the success of weaning NCPAP off in infants born between 23 0/7-30 6/7 weeks of gestational age.

Conditions

  • Neonatal Respiratory Distress Syndrome
  • Extremely Low Birth Weight Infant (ELBW)
  • BronchoPulmonary Dysplasia

Interventions

DEVICE

NCPAP

Nasal Continuous Positive Airway Pressure

Sponsors & Collaborators

  • Children's Hospital of Orange County

    collaborator OTHER

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    lead OTHER

Principal Investigators

  • Virender Rehan, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
26 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819050 on ClinicalTrials.gov